Peloton Wealth Strategists Amgen Inc Transaction History

Peloton Wealth Strategists

$239 Million
Q2 2024

A detailed history of Peloton Wealth Strategists transactions in Amgen Inc stock. As of the latest transaction made, Peloton Wealth Strategists holds 19,143 shares of AMGN stock, worth $6.13 Million. This represents 2.5% of its overall portfolio holdings.

Number of Shares

19,143

Previous 19,423 1.44%

Holding current value

$6.13 Million

Previous $5.52 Million 8.31%

% of portfolio

2.5%

Previous 2.28%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$262.75 - $319.31 $73,570 - $89,406	-280 Reduced 1.44%	19,143 $5.98 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $147,878 - $178,508	-550 Reduced 2.75%	19,423 $5.52 Million
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $199,446 - $224,998	-780 Reduced 3.76%	19,973 $5.75 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $97,955 - $121,614	-448 Reduced 2.11%	20,753 $5.58 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $153,845 - $181,919	-718 Reduced 3.28%	21,201 $4.71 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $33,416 - $40,729	-148 Reduced 0.67%	21,919 $5.3 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $38,935 - $49,471	-170 Reduced 0.76%	22,067 $5.8 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $6,509 - $7,341	29 Added 0.13%	22,237 $5.01 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $126,198 - $140,436	-547 Reduced 2.4%	22,208 $5.4 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $208,745 - $230,926	952 Added 4.37%	22,755 $5.5 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $97,451 - $111,524	490 Added 2.3%	21,803 $4.91 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $433,030 - $507,348	2,040 Added 10.58%	21,313 $4.53 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $809,354 - $897,920	3,465 Added 21.92%	19,273 $4.7 Million
Q1 2021 Jun 23, 2021	BUY	$221.91 - $258.6 $1.35 Million - $1.57 Million	6,070 Added 62.33%	15,808 $3.93 Million
Q4 2020 Feb 17, 2021	BUY	$216.38 - $257.67 $777,886 - $926,323	3,595 Added 58.52%	9,738 $2.24 Million
Q3 2020 Nov 17, 2020	BUY	$234.65 - $260.95 $1.21 Million - $1.35 Million	5,163 Added 526.84%	6,143 $1.56 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $193,853 - $237,885	980 New	980 $231,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peloton Wealth Strategists, based on Form 13F filings with the SEC.

News

Stay updated on Peloton Wealth Strategists with notifications on news.

Account

Peloton Wealth Strategists Amgen Inc Transaction History